Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML
Article in Journal for ImmunoTherapy of Cancer (April 2024)
The most recent citing publications are shown below. View all 38 publications that cite this research output on Dimensions.
Article in Journal for ImmunoTherapy of Cancer (April 2024)
Article in Experimental Hematology & Oncology (April 2024)
Article in Journal of Experimental & Clinical Cancer Research (March 2024)